PMC:7253482 / 0-279 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":19,"end":30},"obj":"Species"},{"id":"3","span":{"begin":31,"end":37},"obj":"Chemical"},{"id":"25","span":{"begin":133,"end":186},"obj":"Species"},{"id":"26","span":{"begin":188,"end":192},"obj":"Species"},{"id":"39","span":{"begin":88,"end":121},"obj":"Disease"},{"id":"40","span":{"begin":123,"end":127},"obj":"Disease"},{"id":"41","span":{"begin":198,"end":206},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"Tax:11118"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D011134"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Tax:1335626"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Tax:11118"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D045169"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D045169"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D015047"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":88,"end":121},"obj":"Disease"},{"id":"T2","span":{"begin":123,"end":127},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":207,"end":216},"obj":"http://purl.obolibrary.org/obo/IDO_0000528"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T0","span":{"begin":0,"end":15},"obj":"NNS"},{"id":"T1","span":{"begin":16,"end":18},"obj":"IN"},{"id":"T2","span":{"begin":19,"end":30},"obj":"NN"},{"id":"T3","span":{"begin":31,"end":37},"obj":"NN"},{"id":"T4","span":{"begin":38,"end":45},"obj":"NNS"},{"id":"T5","span":{"begin":46,"end":53},"obj":"IN"},{"id":"T6","span":{"begin":54,"end":63},"obj":"JJ"},{"id":"T7","span":{"begin":64,"end":77},"obj":"NN"},{"id":"T8","span":{"begin":79,"end":87},"obj":"NN"},{"id":"T9","span":{"begin":88,"end":94},"obj":"JJ"},{"id":"T10","span":{"begin":95,"end":100},"obj":"JJ"},{"id":"T11","span":{"begin":101,"end":112},"obj":"JJ"},{"id":"T12","span":{"begin":113,"end":121},"obj":"NN"},{"id":"T13","span":{"begin":122,"end":123},"obj":"-LRB-"},{"id":"T14","span":{"begin":123,"end":127},"obj":"NN"},{"id":"T15","span":{"begin":127,"end":128},"obj":"-RRB-"},{"id":"T16","span":{"begin":129,"end":132},"obj":"CC"},{"id":"T17","span":{"begin":133,"end":139},"obj":"NNP"},{"id":"T18","span":{"begin":140,"end":144},"obj":"NNP"},{"id":"T19","span":{"begin":145,"end":156},"obj":"JJ"},{"id":"T20","span":{"begin":157,"end":165},"obj":"NN"},{"id":"T21","span":{"begin":166,"end":167},"obj":"-LRB-"},{"id":"T22","span":{"begin":167,"end":171},"obj":"NNS"},{"id":"T23","span":{"begin":171,"end":172},"obj":"-RRB-"},{"id":"T24","span":{"begin":173,"end":186},"obj":"NNS"},{"id":"T25","span":{"begin":187,"end":188},"obj":"-LRB-"},{"id":"T26","span":{"begin":188,"end":192},"obj":"NNS"},{"id":"T27","span":{"begin":192,"end":193},"obj":"-RRB-"},{"id":"T28","span":{"begin":194,"end":197},"obj":"VBP"},{"id":"T29","span":{"begin":198,"end":206},"obj":"JJ"},{"id":"T30","span":{"begin":207,"end":216},"obj":"NNS"},{"id":"T31","span":{"begin":217,"end":221},"obj":"IN"},{"id":"T32","span":{"begin":222,"end":226},"obj":"JJ"},{"id":"T33","span":{"begin":227,"end":235},"obj":"NN"},{"id":"T34","span":{"begin":236,"end":241},"obj":"NNS"},{"id":"T35","span":{"begin":242,"end":245},"obj":"CC"},{"id":"T36","span":{"begin":246,"end":254},"obj":"JJ"},{"id":"T37","span":{"begin":255,"end":264},"obj":"NN"},{"id":"T38","span":{"begin":266,"end":273},"obj":"NN"}],"relations":[{"id":"R6","pred":"arg1Of","subj":"T7","obj":"T6"},{"id":"R7","pred":"arg1Of","subj":"T12","obj":"T9"},{"id":"R8","pred":"arg1Of","subj":"T12","obj":"T10"},{"id":"R9","pred":"arg1Of","subj":"T12","obj":"T11"},{"id":"R0","pred":"arg1Of","subj":"T0","obj":"T1"},{"id":"R1","pred":"arg2Of","subj":"T4","obj":"T1"},{"id":"R2","pred":"arg1Of","subj":"T4","obj":"T2"},{"id":"R3","pred":"arg1Of","subj":"T4","obj":"T3"},{"id":"R4","pred":"arg1Of","subj":"T0","obj":"T5"},{"id":"R5","pred":"arg2Of","subj":"T7","obj":"T5"},{"id":"R10","pred":"arg1Of","subj":"T12","obj":"T13"},{"id":"R11","pred":"arg2Of","subj":"T14","obj":"T13"},{"id":"R12","pred":"arg3Of","subj":"T15","obj":"T13"},{"id":"R13","pred":"arg1Of","subj":"T12","obj":"T16"},{"id":"R14","pred":"arg2Of","subj":"T20","obj":"T16"},{"id":"R15","pred":"arg1Of","subj":"T18","obj":"T17"},{"id":"R16","pred":"arg1Of","subj":"T20","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T20","obj":"T19"},{"id":"R18","pred":"arg1Of","subj":"T20","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"},{"id":"R20","pred":"arg3Of","subj":"T23","obj":"T21"},{"id":"R21","pred":"arg1Of","subj":"T28","obj":"T24"},{"id":"R22","pred":"arg1Of","subj":"T24","obj":"T25"},{"id":"R23","pred":"arg2Of","subj":"T26","obj":"T25"},{"id":"R24","pred":"arg3Of","subj":"T27","obj":"T25"},{"id":"R25","pred":"arg1Of","subj":"T16","obj":"T28"},{"id":"R26","pred":"arg2Of","subj":"T30","obj":"T28"},{"id":"R27","pred":"arg1Of","subj":"T30","obj":"T29"},{"id":"R28","pred":"arg1Of","subj":"T30","obj":"T31"},{"id":"R29","pred":"arg2Of","subj":"T35","obj":"T31"},{"id":"R30","pred":"arg1Of","subj":"T34","obj":"T32"},{"id":"R31","pred":"arg1Of","subj":"T34","obj":"T33"},{"id":"R32","pred":"arg1Of","subj":"T34","obj":"T35"},{"id":"R33","pred":"arg2Of","subj":"T37","obj":"T35"},{"id":"R34","pred":"arg1Of","subj":"T37","obj":"T36"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":88,"end":121},"obj":"Species"},{"id":"T2","span":{"begin":123,"end":127},"obj":"Species"},{"id":"T3","span":{"begin":167,"end":171},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:694009"},{"id":"A2","pred":"ncbi_taxonomy_id","subj":"T2","obj":"NCBItxid:694009"},{"id":"A3","pred":"ncbi_taxonomy_id","subj":"T3","obj":"NCBItxid:1335626"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":77},"obj":"Sentence"},{"id":"T2","span":{"begin":79,"end":87},"obj":"Sentence"},{"id":"T3","span":{"begin":88,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":88,"end":121},"obj":"Disease"},{"id":"T2","span":{"begin":123,"end":127},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"2","span":{"begin":19,"end":30},"obj":"Species"},{"id":"3","span":{"begin":31,"end":37},"obj":"Chemical"},{"id":"39","span":{"begin":88,"end":121},"obj":"Disease"},{"id":"40","span":{"begin":123,"end":127},"obj":"Disease"},{"id":"25","span":{"begin":133,"end":186},"obj":"Species"},{"id":"68","span":{"begin":173,"end":186},"obj":"Species"},{"id":"69","span":{"begin":188,"end":192},"obj":"Species"},{"id":"26","span":{"begin":188,"end":192},"obj":"Species"},{"id":"41","span":{"begin":198,"end":206},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"pubann:denotes","subj":"26","obj":"Tax:11118"},{"id":"A39","pred":"pubann:denotes","subj":"39","obj":"MESH:D045169"},{"id":"A68","pred":"pubann:denotes","subj":"68","obj":"Tax:11118"},{"id":"A25","pred":"pubann:denotes","subj":"25","obj":"Tax:1335626"},{"id":"A3","pred":"pubann:denotes","subj":"3","obj":"MESH:D011134"},{"id":"A2","pred":"pubann:denotes","subj":"2","obj":"Tax:11118"},{"id":"A40","pred":"pubann:denotes","subj":"40","obj":"MESH:D045169"},{"id":"A69","pred":"pubann:denotes","subj":"69","obj":"Tax:11118"},{"id":"A41","pred":"pubann:denotes","subj":"41","obj":"MESH:D015047"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":64,"end":77},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":64,"end":77},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":64,"end":77},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":77},"obj":"Sentence"},{"id":"T2","span":{"begin":79,"end":87},"obj":"Sentence"},{"id":"T3","span":{"begin":88,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation\n\nAbstract\nSevere acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine devel"}